New York State Department of Health Approves CombiSNP Array for Prenatal Diagnosis
CombiMatrix now markets four prenatal and postnatal analysis tests in New York State.
Read MorePosted by Steve Halasey | Aug 24, 2015 | Molecular Diagnostics, Prenatal Testing |
CombiMatrix now markets four prenatal and postnatal analysis tests in New York State.
Read MorePosted by Elaine Sanchez Wilson | Aug 11, 2015 | Cancer |
The 2015 annual meeting of the American Association for Clinical Chemistry saw more than 400 educational sessions, more than 720 exhibitors, and attendance by more than 17,500 medical professionals and healthcare leaders.
Read MorePosted by Steve Halasey | Aug 11, 2015 | Breast, Cancer, Molecular Diagnostics, Research, Womens Health |
The presence of PIK3CA mutations predicts a reduced response to a dual anti-HER2 therapy considered promising in HER2-positive patients without the mutations.
Read MorePosted by Elaine Sanchez Wilson | Aug 4, 2015 | Information Technology |
Deployed as standalone software or integrated with an existing laboratory information system and billing infrastructure, the system is designed to provide automation of laboratory processes, while integrating multiple software systems.
Read MorePosted by Elaine Sanchez Wilson | Jul 20, 2015 | Molecular Diagnostics |
On Tuesday, July 28, from 5:30 pm to 7:30 pm in the International Ballroom North at the Hyatt Regency Atlanta Hotel, panelists will share their clinical experiences in the screening and diagnosis of cervical cancer.
Read More